CureVac N.V. CVAC NASDAQ

CureVac N.V. (CVAC) has shown exceptional revenue growth over the past 3 years, expanding from $103M to $535M (average +280.2%/yr). Net income reached $162M, reflecting exceptional earnings expansion at +65.8%/yr on average. The net profit margin is 30.3%, which is exceptional. the company was profitable in 1 out of the last 4 years tracked. The gross margin is 80.2% (high), with a +211.5pp trend over the period. With a $1B market cap and MOAT composite score of 70/100, the company has a strong competitive position.

Criteria proven by this page:

• GROWTH (100/100, Pass) — proving strong growth momentum
• PAST (25/100, Fail) — the company has frequently reported losses. Looking at the full 7-year history, the company was profitable in 1 of 7 years — a mixed long-term record
• INCOME (100/100, Pass) — proves strong profitability and pricing power
• MOAT (70/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 73/100 with 5/7 criteria passed.